The Indian medical tourism industry has been incessantly growing with medical tourists preferring cardiac treatment procedures, says RNCOS in its latest research study. more »

With the increasing number of diabetic patients and rising insulin demand from the emerging markets, the global insulin market will grow at a CAGR of 15% during 2010-2013, says RNCOS in its latest research study. more »

With the rising population and government support, the UAE healthcare expenditure is expected to grow at a CAGR of 13% during 2007-2012. more »

With new government incentives and policies coming into pipeline, the Indian clinical trials market is expected to grow at a CAGR of around 31% during FY 2010 – FY 2012 more »

Patent expiration of key blockbuster drugs and government support will drive the US generics market during 2010-2013, says RNCOS in its latest research study. more »

With huge human resource and cost competitiveness, the Indian biotech sector will grow at a CAGR of 20% during 2011-2012. more »

Strong demand in the domestic market as well as an increase in exports will drive the growth of the Indian vaccine market, says RNCOS in its latest research study. more »

The healthcare IT market in Australia is projected to grow at a CAGR of over 5% during 2010-2012. more »

The medical insurance industry in UAE is projected to grow at a CAGR of around 42% during 2010-2013, owing to the introduction of compulsory medical insurance. more »

The recent healthcare reform in the US will drive the growth in demand for low-cost Indian generics drugs, says RNCOS in its new research report. more »